Aphexda

Active Ingredient(s): Motixafortide Acetate
FDA Approved: * September 8, 2023
Pharm Company: * BIOLINERX, LTD.
Category: Cancer
* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Aphexda 62 mg/1.7ml Subcutaneous Injection, Powder, Lyophilized, for Solution
NDC: 73441-062
Labeler:
Gamida Cell Inc.
Aphexda 62 mg/1.7ml Subcutaneous Injection, Powder, Lyophilized, for Solution
NDC: 82737-073
Labeler:
Biolinerx USA Inc